Clinical Trials in Lishui, China
Locations / Lishui, China
Delta Trials lists 151 clinical trials conducted in Lishui, China, making it a notable site of clinical research activity. These trials addressing 203 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 2 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Lishui research landscape.
151
Total Trials
203
Conditions
2
Terminated since 2020
Browse by condition (203 total)
- Hepatocellular carcinoma 6 trialsAll Hepatocellular carcinoma trials
- Hypercholesterolemia 5 trialsAll Hypercholesterolemia trials
- Gastric cancer 5 trialsAll Gastric cancer trials
- Adenocarcinoma of the stomach 4 trialsAll Adenocarcinoma of the stomach trials
- All Adenocarcinoma of esophagogastric junction trials
- Hypertension 4 trialsAll Hypertension trials
- Stroke 4 trialsAll Stroke trials
- Obesity 3 trialsAll Obesity trials
- COVID-19 3 trialsAll COVID-19 trials
- Acute ischemic stroke 3 trialsAll Acute ischemic stroke trials
- Esophageal cancer 3 trialsAll Esophageal cancer trials
- Vaccine reaction 3 trialsAll Vaccine reaction trials
- Biliary tract cancer 2 trialsAll Biliary tract cancer trials
- All Atherosclerotic cardiovascular disease (ascvd) trials
- All Compensated advanced chronic liver disease trials
- All Copd (chronic obstructive pulmonary disease) trials
- Candidiasis, invasive 2 trialsAll Candidiasis, invasive trials
- Ventilator associated pneumonia 2 trialsAll Ventilator associated pneumonia trials
- Non-small cell lung cancer 2 trialsAll Non-small cell lung cancer trials
- Heart failure 2 trialsAll Heart failure trials